| Title |
Patient risk factors for developing a drug-related problem in a cardiology ward
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, December 2014
|
| DOI | 10.2147/tcrm.s71749 |
| Pubmed ID | |
| Authors |
Olatz Urbina, Olivia Ferrández, Sònia Luque, Santiago Grau, Sergi Mojal, Rosa Pellicer, Marta Riu, Esther Salas, Josep Comin-Colet |
| Abstract |
Because of the high incidence of drug-related problems (DRPs) among hospitalized patients with cardiovascular diseases and their potential impact on morbidity and mortality, it is important to identify the most susceptible patients, who therefore require closer monitoring of drug therapy. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Unknown | 96 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 22 | 23% |
| Student > Ph. D. Student | 9 | 9% |
| Student > Bachelor | 9 | 9% |
| Researcher | 8 | 8% |
| Student > Postgraduate | 8 | 8% |
| Other | 14 | 14% |
| Unknown | 27 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 30 | 31% |
| Medicine and Dentistry | 19 | 20% |
| Nursing and Health Professions | 4 | 4% |
| Computer Science | 3 | 3% |
| Social Sciences | 3 | 3% |
| Other | 5 | 5% |
| Unknown | 33 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2023.
All research outputs
#2,542,590
of 25,371,288 outputs
Outputs from Therapeutics and Clinical Risk Management
#114
of 1,323 outputs
Outputs of similar age
#33,999
of 369,122 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 15 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,122 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.